Recurrent Hepatosplenic T-Cell Lymphoma: Clinical Trials

3 trials for Recurrent Hepatosplenic T-Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Completed 1, Not yet recruiting 1
Phase 21Active not recruiting 1

Follow Recurrent Hepatosplenic T-Cell Lymphoma: new trials by email Literature Review of Recurrent Hepatosplenic T-Cell Lymphoma trials Research Report on Recurrent Hepatosplenic T-Cell Lymphoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
Azacitidine, Belinostat, Biospecimen Collection - Recurrent Anaplastic Large Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center402027-01-032026-07-09
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
Pembrolizumab, Pralatrexate - Anaplastic Large Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
Phase 1 / Phase 2Active not recruitingCity of Hope Medical Center132019-02-042026-05-26
Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma
Carboplatin, Etoposide, Ifosfamide - Mycosis Fungoides, Recurrent Anaplastic Large Cell Lymphoma
Phase 1CompletedM.D. Anderson Cancer Center222012-10-292018-09-19

Narrower conditions

Enteropathy-Associated T-Cell Lymphoma (3)  ·  Lymphoma, Large-Cell, Anaplastic (3)  ·  Lymphoma, T-Cell (3)  ·  Immunoblastic Lymphadenopathy (2)  ·  Mycosis Fungoides (2)  ·  Subcutaneous panniculitis-like T-cell lymphoma (2)  ·  Lymphoma, Follicular (1)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Lymphadenopathy (2)  ·  Lymphoma, T-Cell, Cutaneous (2)

Interventions

10-propargyl-10-deazaaminopterin (2)  ·  Azacitidine (1)  ·  Carboplatin (1)  ·  Depsipeptides (1)  ·  Etoposide (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Ifosfamide (1)  ·  Lactones (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)  ·  belinostat (1)  ·  pembrolizumab (1)  ·  romidepsin (1)

Sponsors

City of Hope Medical Center (2)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (3)

Top investigators

Alex F Herrera (1)  ·  Christina Poh (1)  ·  Michelle Fanale (1)

Results publications

PMID 29622656

NIH funding

P30CA016672 (1), P30CA033572 (1)